Focused on disease prevention
and health management in animals
SANOFI AND BOEHRINGER INGELHEIM ENTER EXCLUSIVE NEGOTIATIONS ON BUSINESS SWAP
Paris and Ingelheim - December 15, 2015 - Sanofi and Boehringer Ingelheim today announced that the companies have entered into exclusive negotiations to swap businesses. The proposed transaction would consist of an exchange of Sanofi animal health business (“Merial”) with an enterprise value of €11.4 bn and Boehringer Ingelheim consumer healthcare (CHC) business with an enterprise value of €6.7 bn.